Newly identified antibodies target a hard-to-spot region of the influenza virus

FHS
March 1, 2024
7:36 pm

Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored “dark side” of the neuraminidase (NA) protein head.

San Francisco tries tough love by tying welfare to drug rehab

Raymond Llano carries a plastic bag with everything he owns in one hand, a cup of coffee in the other, and the flattened cardboard box

May 13, 2024

Cybin Announces up to US$64 Million Offering of Units | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic

November 10, 2023

AI in medicine, detangling hype, and Icelandic DNA

Has AI really solved biology? What can machines teach us about medicine? And what’s a digital twin? We cover all that and more this week

February 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.